Rating History for Avalyn Pharma (AVLN) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/26/2026 | Judah Frommer | New Coverage | Overweight (N/A) |
53.00 (N/A) |
28.41 (32.97) |
16.05% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/26/2026 | Judah Frommer | New Coverage | Overweight (N/A) |
53.00 (N/A) |
28.41 (32.97) |
16.05% | Details |